CMI vs PSIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CMI

43.2
AI Score
VS
CMI Wins

PSIX

31.1
AI Score

Investment Advisor Scores

CMI

43score
Recommendation
HOLD

PSIX

31score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CMI PSIX Winner
Revenue 17.86B 281.14M CMI
Net Income 1.65B 24.16M CMI
Gross Margin 26.4% 25.2% CMI
Net Margin 9.2% 8.6% CMI
Operating Income 2.23B 35.31M CMI
ROE 12.8% 11.9% CMI
ROA 4.6% 5.3% PSIX
Total Assets 35.63B 453.32M CMI
Cash 3.18B 70.06M CMI
Current Ratio 1.73 2.57 PSIX

Relative Price Performance (Last 90 Days)

CMI 1M: -11.6% · 3M: -8.0% PSIX 1M: +16.1% · 3M: -8.0%

Current Technical Phase

CMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $587.68

PSIX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.6 · Price: $36.43

Fundamentals Snapshot

Metric CMI PSIX
Market Cap
Forward P/E 17.3 11.1
Trailing P/E 31.1 12.6
Revenue (TTM)
Revenue Growth 0.1% -0.2%
Gross Margin 0.3% 0.2%
Operating Margin 0.1% 0.2%
EPS 19.10 2.95
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, CMI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.